Michael Lam is a therapeutics R&D professional with 16 years of experience across large pharmaceutical companies, biotech startups, and venture-backed early-stage companies. His work spans small molecule discovery, gene editing technologies such as CRISPR and base editing, and translational research aimed at advancing new therapies to the clinic.
He has contributed to efforts in target validation, lead optimization, and IND-enabling studies, and is experienced in guiding programs through key decision points using both internal and outsourced resources. Michael has managed cross-functional teams and worked across therapeutic areas, with a particular focus on linking scientific strategy to patient outcomes.
Earlier in his career, Michael was an early employee at a venture-backed biotech startup, and helped grow the company to over 80 employees, gaining experience in organizational development, operations, and scientific leadership.
Can help with
- Advising on early-stage therapeutics discovery strategies, particularly for small molecules, gene editing approaches, and cell therapies
- Discussing approaches to translational science, including patient and disease selection, biomarker strategies, and therapeutic window analysis
- Sharing practical experience with CRO partnerships and external R&D management
- Offering insights into company formation, team building, and scaling operations in a startup setting
- Therapeutics discovery for small molecules, gene editing, and cell therapies.
- Translational sciences
- Contract research organizations
